Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10287-53-3

Post Buying Request

10287-53-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10287-53-3 Usage

Chemical Properties

white crystalline powder

Uses

Different sources of media describe the Uses of 10287-53-3 differently. You can refer to the following data:
1. Ethyl 4-dimethylaminobenzoate is employed as a photoinititator in cell encapsulation applications. It is also useful for organic synthesis. Further, it is used in UV-curing coatings and inks for the initiation of photo polymerization of unsaturated prepolymers. In addition to this, it acts as a active pharmaceutical ingredient intermediate.
2. Et-PABA is used as a co-initiator with camphorquinone (CQ) to form a self-adhesive composite for the fabrication of photosensitizers in dental materials.

Definition

ChEBI: A benzoate ester that is ethyl benzoate substituted by a dimethylamino group at position 4.

Flammability and Explosibility

Notclassified

Check Digit Verification of cas no

The CAS Registry Mumber 10287-53-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,2,8 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 10287-53:
(7*1)+(6*0)+(5*2)+(4*8)+(3*7)+(2*5)+(1*3)=83
83 % 10 = 3
So 10287-53-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO2/c1-4-8-7-9(12(2)3)5-6-10(8)11(13)14/h5-7H,4H2,1-3H3,(H,13,14)/p-1

10287-53-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A12888)  Ethyl 4-dimethylaminobenzoate, 99%   

  • 10287-53-3

  • 25g

  • 149.0CNY

  • Detail
  • Alfa Aesar

  • (A12888)  Ethyl 4-dimethylaminobenzoate, 99%   

  • 10287-53-3

  • 100g

  • 584.0CNY

  • Detail
  • Alfa Aesar

  • (A12888)  Ethyl 4-dimethylaminobenzoate, 99%   

  • 10287-53-3

  • 500g

  • 2337.0CNY

  • Detail
  • Sigma-Aldrich

  • (42582)  Ethyl4-(dimethylamino)benzoate  Standard for quantitative NMR, TraceCERT®

  • 10287-53-3

  • 42582-1G

  • 1,731.60CNY

  • Detail
  • Aldrich

  • (E24905)  Ethyl4-(dimethylamino)benzoate  ≥99%

  • 10287-53-3

  • E24905-5G

  • 475.02CNY

  • Detail
  • Aldrich

  • (E24905)  Ethyl4-(dimethylamino)benzoate  ≥99%

  • 10287-53-3

  • E24905-100G

  • 920.79CNY

  • Detail
  • Aldrich

  • (E24905)  Ethyl4-(dimethylamino)benzoate  ≥99%

  • 10287-53-3

  • E24905-500G

  • 3,045.51CNY

  • Detail

10287-53-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name parbenate

1.2 Other means of identification

Product number -
Other names ethyl 4-(dimethylamino)benzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10287-53-3 SDS

10287-53-3Relevant articles and documents

Combretastatin linked 1,3,4-oxadiazole conjugates as a Potent Tubulin Polymerization inhibitors

Kamal, Ahmed,Srikanth,Vishnuvardhan,Kumar, G. Bharath,Suresh Babu, Korrapati,Hussaini, S.M. Ali,Kapure, Jeevak Sopanrao,Alarifi, Abdullah

, p. 126 - 136 (2016)

A new class of combretastatin linked 1,3,4-oxadiazoles were designed, synthesized and screened for their cytotoxic activity against five human cancer cell lines such as HeLa, DU-145, A549, MDA-MB-231 and B16. These compounds showed significant cytotoxicity with IC50 values in the range 0.118-54.32 μM. Conjugate 5m displayed potent antiproliferative activity against DU-145 cell line. Flow cytometric analysis revealed that these compounds arrested the cell cycle in G2/M phase. Moreover, the tubulin polymerization assay and immunofluorescence analysis indicate that 5m exhibits potent inhibitory effect on the tubulin assembly. Further, DNA fragmentation and Hoecst staining assays confirm that 5m induces apoptosis. Molecular docking studies and competitive binding assay indicated that 5m effectively bind at the colchicine binding site of the tubulin.

The dual role of ionic liquid BmimBF4, precursor of N-heterocyclic carbene and solvent, in the oxidative esterification of aldehydes

Chiarotto, Isabella,Feroci, Marta,Sotgiu, Giovanni,Inesi, Achille

, p. 8088 - 8095 (2013)

Room temperature ionic liquid BmimBF4 (1-butyl-3- methylimidazolium tetrafluoroborate) has been utilized in the N-heterocyclic carbene-catalyzed oxidation of aldehydes to yield esters. In the presence of MnO2 as oxidant and of DBU and caesium carbonate as bases, aromatic, heteroaromatic and aliphatic esters have been isolated in good to excellent yields. The recyclability of the used ionic liquid along with the excess of inorganic reagents has been proved. The simple and cheap BmimBF4 ionic liquid played the dual role of precatalyst and solvent. This is the first time that such a reaction has been carried out with an ionic liquid as solvent.

Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker

Liu, Jie,Zhang, Guang-Yu,Zhang, Zhe,Li, Bo,Chai, Fei,Wang, Qi,Zhou, Zi-Dan,Xu, Ling-Ling,Wang, Shou-Kai,Jin, Zhen,Tang, You-Zhi

, (2021/05/17)

A class of pleuromutilin derivatives containing 1, 3, 4-oxadiazole were designed and synthesized as potential antibacterial agents against Methicillin-resistant staphylococcus aureus (MRSA). The ultrasound-assisted reaction was proposed as a green chemistry method to synthesize 1, 3, 4-oxadiazole derivatives (intermediates 85–110). Among these pleuromutilin derivatives, compound 133 was found to be the strongest antibacterial derivative against MRSA (MIC = 0.125 μg/mL). Furthermore, the result of the time-kill curves displayed that compound 133 could inhibit the growth of MRSA in vitro quickly (- 4.36 log10 CFU/mL reduction). Then, compound 133 (- 1.82 log10 CFU/mL) displayed superior in vivo antibacterial efficacy than tiamulin (- 0.82 log10 CFU/mL) in reducing MRSA load in mice thigh model. Besides, compound 133 exhibited low cytotoxicity to RAW 264.7 cells. Molecular docking studies revealed that compound 133 was successfully localized in the binding pocket of 50S ribosomal subunit (ΔGb = -10.50 kcal/mol). The results indicated that these pleuromutilin derivatives containing 1, 3, 4-oxadiazole might be further developed into novel antibiotics against MRSA.

Metal-Free Deoxygenation of Amine N-Oxides: Synthetic and Mechanistic Studies

Lecroq, William,Schleinitz, Jules,Billoue, Mallaury,Perfetto, Anna,Gaumont, Annie-Claude,Lalevée, Jacques,Ciofini, Ilaria,Grimaud, Laurence,Lakhdar, Sami

, p. 1237 - 1242 (2021/06/01)

We report herein an unprecedented combination of light and P(III)/P(V) redox cycling for the efficient deoxygenation of aromatic amine N-oxides. Moreover, we discovered that a large variety of aliphatic amine N-oxides can easily be deoxygenated by using only phenylsilane. These practically simple approaches proceed well under metal-free conditions, tolerate many functionalities and are highly chemoselective. Combined experimental and computational studies enabled a deep understanding of factors controlling the reactivity of both aromatic and aliphatic amine N-oxides.

Pleuromutilin derivative with 1, 3, 4-oxadiazole side chain and preparation and application thereof

-

Paragraph 0055-0056; 0070; 0090; 0092; 0095; 0103, (2021/07/24)

The invention belongs to the field of medicinal chemistry, and particularly relates to a pleuromutilin derivative with a 1, 3, 4-oxadiazole side chain and preparation and application thereof The pleuromutilin derivative with the 1, 3, 4-oxadiazole side chain is a compound shown in a formula 2 or a pharmaceutically acceptable salt thereof, and a solvent compound, an enantiomer, a diastereoisomer and a tautomer of the compound shown in the formula 2 or the pharmaceutically acceptable salt thereof or a mixture of the solvent compound, the enantiomer, the diastereoisomer and the tautomer in any proportion, including a racemic mixture. The pleuromutilin derivative has good antibacterial activity, is especially suitable for being used as a novel antibacterial agent for systemic system infection of animals or human beings, and has good water solubility.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10287-53-3